The Society of Cardiovascular Computed Tomography has developed a new expert consensus document designed to get physicians on the same page when discussing this growing technology.
Emily Lau, MD, a women's health expert with Massachusetts General Hospital, thinks major changes are needed in how we diagnose CVD in women. "Our guidelines need to be more precise and offer sex-specific recommendations," she says.
Innovalve Bio Medical's Innostay transcatheter mitral valve replacement device. Image courtesy of Innovalve Bio Medical.
Edwards, an early investor when the company first launched in 2017, said the acquisition will ensure its TMVR platform reaches as many patients as possible.
In rural Oklahoma, double amputees due to untreated peripheral artery disease face mortality rates around 35% after one year and 60% after two. Jim Melton, DO, hopes his mobile cardiology clinics can make a difference for these patients.
Among general cardiologists, compensation increased nearly 8% from 2023 to 2024. Interventional cardiology and electrophysiology saw even larger jumps.
The self-expanding valve is not yet approved by the FDA, but care teams in other markets are reporting positive outcomes when patients go home the day after treatment.
Quantification results of mean LV and RV volumes of automated four-chamber and short-axis segmentation methods over time. a AI-generated contours of short-axis cine stack of images using standard endocardial and epicardial contour methods. b AI-generated four-chamber cine segmentation contours using standard endocardial and epicardial contours methods. c AI-generated four-chamber cine segmentation results yielded slightly lower LV and RV volumes than the ground truth. d Quantification results of automated four-chamber mean LV and RV volumes after applying 14.56 mL and 50.78 mL correction factors and short-axis segmentation results over time. Images/caption courtesy of European Radiology Experimental.
New data out of England provides cardiologists and radiologists with another reminder of AI's potential to transform healthcare.
Both tirzepatide (Mounjaro) and semaglutide (Ozempic) have made headlines in recent months for their benefits in broad patient populations. This new analysis compared the two medications in obese/overweight adults with and without type 2 diabetes.
Researchers explored more than 100,000 online reviews, using AI to learn as much as possible about what drives patients to give their cardiologist a positive or negative rating.
